@prefix n9j: <http://data.loterre.fr/ark:/67375/N9J> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix isothes: <http://purl.org/iso25964/skos-thes#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

n9j:-X53K2K0F-1
  skos:prefLabel "treatment theories, research, techniques, strategies, and effectiveness"@en ;
  a skos:Concept ;
  skos:narrower n9j:-G09CR1H7-7 .

n9j: a skos:ConceptScheme .
n9j:-MB48CG9B-5
  skos:prefLabel "drug classification"@en ;
  a skos:Concept ;
  skos:narrower n9j:-G09CR1H7-7 .

n9j:-concepts
  a isothes:ConceptGroup ;
  skos:prefLabel "concepts"@en ;
  skos:member n9j:-G09CR1H7-7 .

n9j:-G09CR1H7-7
  owl:sameAs <https://concepts.sagepub.com/social-science/concept/naltrexone> ;
  skos:definition "Naltrexone is a medication that has been found to be efficacious in the treatment of opioid (e.g., heroin, morphine) and alcohol dependence. In 50-milligram (mg) pill form (the dose approved by the U.S. Food and Drug Administration [FDA]), naltrexone goes by the trade name Re Via. [Source: Encyclopedia of Substance Abuse Prevention, Treatment, & Recovery; Naltrexone]"@en ;
  a skos:Concept ;
  skos:inScheme n9j: ;
  skos:broader n9j:-X53K2K0F-1, n9j:-MB48CG9B-5 ;
  skos:prefLabel "naltrexone"@en .